Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study.
Diabetes mellitus
Erectile dysfunction
Metabolic syndrome
Obesity
Testosterone
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
08
01
2023
accepted:
09
02
2023
pubmed:
29
7
2023
medline:
29
7
2023
entrez:
29
7
2023
Statut:
ppublish
Résumé
The clinical significance of metabolic syndrome (MetS) versus its single components in erectile dysfunction (ED) is conflicting. Thus, the purpose is to analyze the available evidence on the relationship between MetS-along with its components-and ED. All prospective and retrospective observational studies reporting information on ED and MetS were included. In addition, we here reanalyzed preclinical and clinical data obtained from a previously published animal model of MetS and from a consecutive series of more than 2697 men (mean age: 52.7 ± 12), respectively. Data derived from this meta-analysis showed that MetS was associated with an up to fourfold increased risk of ED when either unadjusted or adjusted data were considered. Meta-regression analysis, performed using unadjusted statistics, showed that the MetS-related risk of ED was closely associated with all the MetS components. These associations were confirmed when unadjusted analyses from clinical models were considered. However, fully adjusted data showed that MetS-associated ED was more often due to morbidities included (or not) in the algorithm than to the MetS diagnostic category itself. MetS is also associated with low testosterone, but its contribution to MetS-associated ED-as derived from preclinical and clinical models-although independent, is marginal. The results of our analysis suggest that MetS is a useless diagnostic category for studying ED. However, treating the individual MetS components is important, because they play a pivotal role in determining ED.
Identifiants
pubmed: 37515706
doi: 10.1007/s40618-023-02136-x
pii: 10.1007/s40618-023-02136-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2195-2211Informations de copyright
© 2023. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
Références
Lotti F, Marchiani S, Corona G, Maggi M (2021) Metabolic syndrome and reproduction. Int J Mol Sci 22(4):1988. https://doi.org/10.3390/ijms22041988
Esposito K, Giugliano F, Martedì E, Feola G, Marfella R, D’Armiento M et al (2005) High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 28(5):1201–1203
pubmed: 15855589
doi: 10.2337/diacare.28.5.1201
Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al (2006) Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 50(3):595–604 (discussion)
Demir T, Demir O, Kefi A, Comlekci A, Yesil S, Esen A (2006) Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 13(4):385–388
pubmed: 16734855
doi: 10.1111/j.1442-2042.2006.01310.x
Liu LH, Zhang T, Zhang YR, Liu TS, Zhang HB, Chen FZ et al (2014) Metabolic syndrome and risk for ED: a meta-analysis. Int J Impot Res 26(5):196–200
pubmed: 24599048
doi: 10.1038/ijir.2014.3
Besiroglu H, Otunctemur A, Ozbek E (2015) The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med 12(6):1309–1318
pubmed: 25872648
doi: 10.1111/jsm.12885
Corona G, Rastrelli G, Isidori AM, Pivonello R, Bettocchi C, Reisman Y et al (2020) Erectile dysfunction and cardiovascular risk: a review of current findings. Expert Rev Cardiovasc Ther 18(3):155–164
pubmed: 32192361
doi: 10.1080/14779072.2020.1745632
Antonio L, Wu FCW, Moors H, Matheï C, Huhtaniemi IT, Rastrelli G et al (2022) Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status. Age Ageing 51(4):afac094. https://doi.org/10.1093/ageing/afac094
Corona G, Rastrelli G, Balercia G, Lotti F, Sforza A, Monami M et al (2012) Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. J Sex Med 9(6):1669–1680
pubmed: 22489756
doi: 10.1111/j.1743-6109.2012.02717.x
Corona G, Monami M, Rastrelli G, Melani C, Balzi D, Sforza A et al (2011) Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction. J Sex Med 8(2):504–511
pubmed: 21091887
doi: 10.1111/j.1743-6109.2010.02126.x
Corona G, Maggi M (2022) The role of testosterone in male sexual function. Rev Endocr Metab Disord 23(6):1159–1172
pubmed: 35999483
pmcid: 9789013
doi: 10.1007/s11154-022-09748-3
Corona G, Rastrelli G, Vignozzi L, Maggi M (2022) Androgens and male sexual function. Best Pract Res Clin Endocrinol Metab 36(4):101615. https://doi.org/10.1016/j.beem.2022.101615
doi: 10.1016/j.beem.2022.101615
pubmed: 35153145
Corona G, Torres LO, Maggi M (2020) Testosterone therapy: what we have learned from trials. J Sex Med 17(3):447–460
pubmed: 31928918
doi: 10.1016/j.jsxm.2019.11.270
Rastrelli G, Corona G, Maggi M (2018) Testosterone and sexual function in men. Maturitas 112:46–52
pubmed: 29704917
doi: 10.1016/j.maturitas.2018.04.004
Rastrelli G, Guaraldi F, Reismann Y, Sforza A, Isidori AM, Maggi M et al (2019) Testosterone replacement therapy for sexual symptoms. Sex Med Rev. 7(3):464–475
pubmed: 30803919
doi: 10.1016/j.sxmr.2018.11.005
Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F et al (2011) Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 8(1):272–283
pubmed: 20807333
doi: 10.1111/j.1743-6109.2010.01991.x
Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B et al (2009) Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med 6(12):3274–3288
pubmed: 19732305
doi: 10.1111/j.1743-6109.2009.01467.x
Morelli A, Filippi S, Comeglio P, Sarchielli E, Cellai I, Pallecchi M et al (2019) Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. Am J Physiol Endocrinol Metab 316(3):E519–E535
pubmed: 30645174
doi: 10.1152/ajpendo.00377.2018
Marchiani S, Vignozzi L, Filippi S, Gurrieri B, Comeglio P, Morelli A et al (2015) Metabolic syndrome-associated sperm alterations in an experimental rabbit model: relation with metabolic profile, testis and epididymis gene expression and effect of tamoxifen treatment. Mol Cell Endocrinol 401:12–24
pubmed: 25451982
doi: 10.1016/j.mce.2014.11.005
Morelli A, Sarchielli E, Comeglio P, Filippi S, Vignozzi L, Marini M et al (2014) Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Mol Cell Endocrinol 382(1):107–119
pubmed: 24064031
doi: 10.1016/j.mce.2013.09.017
Corona G, Mannucci E, Petrone L, Fisher AD, Balercia G, De Scisciolo G et al (2006) Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. J Androl 27(3):453–458
pubmed: 16339452
doi: 10.2164/jandrol.05154
Corona G, Ricca V, Bandini E, Mannucci E, Petrone L, Fisher AD et al (2008) Association between psychiatric symptoms and erectile dysfunction. J Sex Med 5(2):458–468
pubmed: 18004996
doi: 10.1111/j.1743-6109.2007.00663.x
Bal K, Oder M, Sahin AS, Karataş CT, Demir O, Can E et al (2007) Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology 69(2):356–360
pubmed: 17275074
doi: 10.1016/j.urology.2006.09.057
Yeh HC, Wang CJ, Lee YC, Hsiao HL, Wu WJ, Chou YH et al (2008) Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. Kaohsiung J Med Sci 24(5):240–247
pubmed: 18508421
doi: 10.1016/S1607-551X(08)70148-7
Demir O, Demir T, Kefi A, Secil M, Comlekci A, Yesil S et al (2009) Penile vascular impairment in erectile dysfunction patients with metabolic syndrome: penile Doppler ultrasound findings. Urol Int 82(2):175–178
pubmed: 19322005
doi: 10.1159/000200795
Gatti A, Mandosi E, Fallarino M, Radicioni A, Morini E, Maiani F et al (2009) Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects. J Endocrinol Investig 32(6):542–545
doi: 10.1007/BF03346504
Koca O, Calışkan S, Oztürk M, Güneş M, Kılıçoğlu G, Karaman MI (2010) Vasculogenic erectile dysfunction and metabolic syndrome. J Sex Med 7(12):3997–4002
pubmed: 20584111
doi: 10.1111/j.1743-6109.2010.01932.x
Lee YC, Liu CC, Huang CN, Li WM, Wu WJ, Yeh HC et al (2010) The potential impact of metabolic syndrome on erectile dysfunction in aging Taiwanese males. J Sex Med 7(9):3127–3134
pubmed: 20546117
doi: 10.1111/j.1743-6109.2010.01852.x
Aktas BK, Gokkaya CS, Bulut S, Dinek M, Ozden C, Memis A (2011) Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male 14(1):48–52
pubmed: 21087172
doi: 10.3109/13685538.2010.529197
Pohjantähti-Maaroos H, Palomäki A (2011) Comparison of metabolic syndrome subjects with and without erectile dysfunction—levels of circulating oxidised LDL and arterial elasticity. Int J Clin Pract 65(3):274–280
pubmed: 21314864
doi: 10.1111/j.1742-1241.2010.02595.x
Tan WS, Ng CJ, Khoo EM, Low WY, Tan HM (2011) The triad of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome: findings from a multi-ethnic Asian men study (The Subang Men’s Health Study). Aging Male 14(4):231–236
pubmed: 22115177
doi: 10.3109/13685538.2011.597463
Chao JK, Kuo WH, Chiang HS, Hwang TI, Chao IC, Chiang SK (2012) Association of metabolic syndrome, atherosclerosis risk factors, sex hormones in ED in aboriginal Taiwanese. Int J Impot Res 24(4):141–146
Chen K, Mi H, Gao Y, Tan A, Lu Z, Wu C et al (2012) Metabolic syndrome: a potential and independent risk factor for erectile dysfunction in the Chinese male population. Urology 80(6):1287–1292
pubmed: 23040724
doi: 10.1016/j.urology.2012.08.028
García-Cruz E, Leibar-Tamayo A, Romero J, Piqueras M, Luque P, Cardeñosa O et al (2013) Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med 10(10):2529–2538
pubmed: 23898860
doi: 10.1111/jsm.12265
Weinberg AE, Eisenberg M, Patel CJ, Chertow GM, Leppert JT (2013) Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction. J Sex Med 10(12):3102–3109
pubmed: 24010555
pmcid: 3891923
doi: 10.1111/jsm.12318
Aslan Y, Guzel O, Balci M, Tuncel A, Yildiz M, Atan A (2014) The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. Aging Male 17(2):76–80
pubmed: 24576299
doi: 10.3109/13685538.2014.895318
Gorgel SN, Gorgel A, Sefik E (2014) Sexual function in male patients with metabolic syndrome and effective parameters on erectile dysfunction. Int Braz J Urol 40(1):56–61
pubmed: 24642150
doi: 10.1590/S1677-5538.IBJU.2014.01.08
Park JH, Cho IC, Kim YS, Kim SK, Min SK, Kye SS (2015) Body mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men’s health. Korean J Urol 56(5):386–392
pubmed: 25964840
pmcid: 4426511
doi: 10.4111/kju.2015.56.5.386
Chaudhary RK, Shamsi BH, Tan T, Chen HM, Xing JP (2016) Study of the relationship between male erectile dysfunction and type 2 diabetes mellitus/metabolic syndrome and its components. J Int Med Res 44(3):735–741
pubmed: 27036148
pmcid: 5536719
doi: 10.1177/0300060515623122
De Nunzio C, Lombardo R, Gacci M, Nacchia A, Presicce F, Alkhatatbeh H et al (2017) Metabolic syndrome does not increase the risk of ejaculatory dysfunction in patients with lower urinary tract symptoms and benign prostatic enlargement: an Italian single-center cohort study. Urology 105:85–90
pubmed: 28412335
doi: 10.1016/j.urology.2017.04.007
Erkoc M, Besiroglu H, Otunctemur A, Polat EC, Bozkurt M (2020) Metabolic syndrome is associated worsened erectile function in patients undergoing TURP due to benign prostatic hyperplasia. Aging Male 23(5):533–537
pubmed: 30468407
doi: 10.1080/13685538.2018.1541133
Salama MN, Eid AA, Hatem A, Swidan AK (2020) Prevalence of erectile dysfunction in Egyptian males with metabolic syndrome. Aging Male 23(4):257–263
pubmed: 29921153
doi: 10.1080/13685538.2018.1479736
Bolat MS, Ozbek ML, Şahin B, Yılmaz M, Kocamanoglu F, Buyukalpelli R et al (2021) Impact of high visceral adiposity index associated with metabolic syndrome on erectile function in sexually active men: results of a cross-sectional study. Int J Clin Pract 75(6):e14111
pubmed: 33621419
doi: 10.1111/ijcp.14111
Neuzillet Y, Dreyfus JF, Raynaud JP, Rouanne M, Schneider M, Roupret M et al (2021) Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomy. Asian J Androl 23(5):520–526
pubmed: 33762475
pmcid: 8451490
doi: 10.4103/aja.aja_3_21
Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60(5):1010–1016
pubmed: 21855209
doi: 10.1016/j.eururo.2011.07.053
Corona G, Rastrelli G, Vignozzi L, Barbonetti A, Sforza A, Mannucci E et al (2021) The role of testosterone treatment in patients with metabolic disorders. Expert Rev Clin Pharmacol 14(9):1091–1103. https://doi.org/10.1080/17512433.2021.1938548
doi: 10.1080/17512433.2021.1938548
pubmed: 34085587
Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G et al (2020) European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: endorsing organization: European Society of Endocrinology. Andrology 8(5):970–987
pubmed: 32026626
doi: 10.1111/andr.12770
Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC et al (2021) European Association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol 80(3):333–357
pubmed: 34183196
doi: 10.1016/j.eururo.2021.06.007
Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F et al (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45(12):2385–2403. https://doi.org/10.1007/s40618-022-01859-
doi: 10.1007/s40618-022-01859-
pubmed: 36018454
pmcid: 9415259
Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S (2016) Animal models of metabolic syndrome: a review. Nutr Metab (Lond) 13:65
pubmed: 27708685
doi: 10.1186/s12986-016-0123-9
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y et al (2022) Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786. https://doi.org/10.3390/ijms23020786
doi: 10.3390/ijms23020786
pubmed: 35054972
pmcid: 8775991
Pitsavos C, Panagiotakos D, Weinem M, Stefanadis C (2006) Diet, exercise and the metabolic syndrome. Rev Diabet Stud 3(3):118–126
pubmed: 17487335
pmcid: 1783583
doi: 10.1900/RDS.2006.3.118
Vignozzi L, Filippi S, Comeglio P, Cellai I, Morelli A, Marchetta M et al (2014) Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. J Sex Med 11(12):2890–2902
pubmed: 25243860
doi: 10.1111/jsm.12695
Maggi R, Zasso J, Conti L (2014) Neurodevelopmental origin and adult neurogenesis of the neuroendocrine hypothalamus. Front Cell Neurosci 8:440
pubmed: 25610370
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752
pubmed: 16157765
doi: 10.1161/CIRCULATIONAHA.105.169404
Rastrelli G, Filippi S, Sforza A, Maggi M, Corona G (2018) Metabolic syndrome in male hypogonadism. Front Horm Res 49:131–155
pubmed: 29895018
doi: 10.1159/000485999
Von Korff M, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data. J Clin Epidemiol 45(2):197–203
doi: 10.1016/0895-4356(92)90016-G
Rastrelli G, Corona G, Maggi M (2020) Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction. Asian J Androl 22(3):265–273
pubmed: 31249270
doi: 10.4103/aja.aja_61_19
Brand JS, Rovers MM, Yeap BB, Schneider HJ, Tuomainen TP, Haring R et al (2014) Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS ONE 9(7):e100409
pubmed: 25019163
pmcid: 4096400
doi: 10.1371/journal.pone.0100409
Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R et al (2003) Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res 15(3):210–220
pubmed: 12904808
doi: 10.1038/sj.ijir.3901006
Corona G, Sansone A, Pallotti F, Ferlin A, Pivonello R, Isidori AM et al (2020) People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction. J Endocrinol Investig 43(10):1391–1408
doi: 10.1007/s40618-020-01257-x
Marieke D, Joana C, Giovanni C, Erika L, Patricia P, Yacov R et al (2020) Sexual desire discrepancy: a position statement of the european society for sexual medicine. Sex Med 8(2):121–131
pubmed: 32192965
pmcid: 7261674
doi: 10.1016/j.esxm.2020.02.008
Dewitte M, Bettocchi C, Carvalho J, Corona G, Flink I, Limoncin E et al (2021) A psychosocial approach to erectile dysfunction: position statements from the European Society of Sexual Medicine (ESSM). Sex Med 9(6):100434
pubmed: 34626919
pmcid: 8766276
doi: 10.1016/j.esxm.2021.100434
Boddi V, Corona G, Fisher AD, Mannucci E, Ricca V, Sforza A et al (2012) “It takes two to tango”: the relational domain in a cohort of subjects with erectile dysfunction (ED). J Sex Med 9(12):3126–3136
pubmed: 23036015
doi: 10.1111/j.1743-6109.2012.02948.x
Corona G, Ricca V, Bandini E, Rastrelli G, Casale H, Jannini EA et al (2012) SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. J Sex Med 9(8):2017–2026
pubmed: 22594968
doi: 10.1111/j.1743-6109.2012.02762.x
Grossmann M, Mg Tang Fui M, Cheung AS (2020) Late-onset hypogonadism: metabolic impact. Andrology 8(6):1519–1529
pubmed: 31502758
doi: 10.1111/andr.12705
Corona G, Isidori AM, Aversa A, Burnett AL, Maggi M (2016) Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med 13(3):317–337
pubmed: 26944463
doi: 10.1016/j.jsxm.2016.01.007
Corona G, Rastrelli G, Ricca V, Jannini EA, Vignozzi L, Monami M et al (2013) Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction. J Sex Med 10(4):1074–1089
pubmed: 23347078
doi: 10.1111/jsm.12043
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM et al (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(5):1715–1744
pubmed: 29562364
doi: 10.1210/jc.2018-00229
Lunenfeld B, Mskhalaya G, Zitzmann M, Corona G, Arver S, Kalinchenko S et al (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. Aging Male 24(1):119–138
pubmed: 34396893
doi: 10.1080/13685538.2021.1962840
Sun K, Ren M, Liu D, Wang C, Yang C, Yan L (2014) Alcohol consumption and risk of metabolic syndrome: a meta-analysis of prospective studies. Clin Nutr 33(4):596–602
pubmed: 24315622
doi: 10.1016/j.clnu.2013.10.003
Sun K, Liu J, Ning G (2012) Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS ONE 7(10):e47791
pubmed: 23082217
pmcid: 3474781
doi: 10.1371/journal.pone.0047791
Lee G, Choi HY, Yang SJ (2015) Effects of dietary and physical activity interventions on metabolic syndrome: a meta-analysis. J Korean Acad Nurs 45(4):483–494
pubmed: 26364523
doi: 10.4040/jkan.2015.45.4.483
Castro VMF, Melo AC, Belo VS, Chaves VE (2017) Effect of allopurinol and uric acid normalization on serum lipids hyperuricemic subjects: a systematic review with meta-analysis. Clin Biochem 50(18):1289–1297
pubmed: 28754333
doi: 10.1016/j.clinbiochem.2017.07.013
Kwon OY, Choi JY, Jang Y (2023) The effectiveness of ehealth interventions on lifestyle modification in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis. J Med Internet Res 25:e37487
pubmed: 36689264
pmcid: 9903182
doi: 10.2196/37487
Sansone A, Reisman Y, Jannini EA (2022) Relationship between hyperuricemia with deposition and sexual dysfunction in males and females. J Endocrinol Investig 45(4):691–703
doi: 10.1007/s40618-021-01719-w
Hasanain AFA, Mahdy RE, Mahran AMA, Safwat ASM, Mohamed AO, Abdel-Aal SM (2017) Erectile dysfunction in patients with nonalcoholic fatty liver disease. Arab J Gastroenterol 18(1):21–24
pubmed: 28325476
doi: 10.1016/j.ajg.2017.02.002
Wang XY, Huang W, Zhang Y (2018) Relation between hypertension and erectile dysfunction: a meta-analysisof cross-section studies. Int J Impot Res 30(3):141–146
pubmed: 29785046
doi: 10.1038/s41443-018-0020-z
Behr-Roussel D, Gorny D, Mevel K, Compagnie S, Kern P, Sivan V et al (2005) Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 288(1):R276–R283
pubmed: 15297263
doi: 10.1152/ajpregu.00040.2004
Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L et al (2008) Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. J Androl 29(1):70–84
pubmed: 17699803
doi: 10.2164/jandrol.107.003152
Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G et al (2009) Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6(1):285–293
Corona G, Monami M, Boddi V, Rastrelli G, Melani C, Balzi D et al (2011) Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. J Sex Med 8(1):247–254
pubmed: 20722787
doi: 10.1111/j.1743-6109.2010.01966.x
Farmakis IT, Pyrgidis N, Doundoulakis I, Mykoniatis I, Akrivos E, Giannakoulas G (2021) Effects of major antihypertensive drug classes on erectile function: a network meta-analysis. Cardiovasc Drugs Ther 36(5):903–914
pubmed: 33945044
doi: 10.1007/s10557-021-07197-9
Farmakis IT, Pyrgidis N, Doundoulakis I, Mykoniatis I, Akrivos E, Giannakoulas G (2022) Effects of major antihypertensive drug classes on erectile function: a network meta-analysis. Cardiovasc Drugs Ther 36(5):903–914
pubmed: 33945044
doi: 10.1007/s10557-021-07197-9
Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A et al (2017) High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 34(9):1185–1192
pubmed: 28722225
doi: 10.1111/dme.13403
Corona G, Rastrelli G, Silverii A, Monami M, Sforza A, Forti G et al (2013) The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction. J Sex Med 10(4):1114–1123
pubmed: 23347470
doi: 10.1111/jsm.12066
Jin M, Yuan S, Wang B, Yi L, Wang C (2021) Association between prediabetes and erectile dysfunction: a meta-analysis. Front Endocrinol (Lausanne) 12:733434
pubmed: 35082752
doi: 10.3389/fendo.2021.733434
Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E et al (2000) Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 29(3):524–531
pubmed: 10869326
doi: 10.1093/ije/29.3.524
Corona G, Bianchini S, Sforza A, Vignozzi L, Maggi M (2015) Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones (Athens) 14(4):569–578
pubmed: 26732155
Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Jannini EA (2022) Sexual dysfunction in men and women with diabetes: a reflection of their complications? Curr Diabetes Rev 18(1):e030821192147
pubmed: 33687898
doi: 10.2174/1573399817666210309104740
Li M, Ma Z, Zhang XL, Guo LQ, Yuan MZ (2020) Significance of blood lipid parameters as effective markers for arteriogenic erectile dysfunction. Andrology 8(5):1086–1094
pubmed: 32087037
doi: 10.1111/andr.12776
Corona G, Cipriani S, Rastrelli G, Sforza A, Mannucci E, Maggi M (2016) High triglycerides predicts arteriogenic erectile dysfunction and major adverse cardiovascular events in subjects with sexual dysfunction. J Sex Med 13(9):1347–1358
pubmed: 27555506
doi: 10.1016/j.jsxm.2016.07.004
Xu ZH, Xu HX, Jiang S, Xu QF, Ding K, Zhang DX et al (2021) Effect of high-density lipoprotein on penile erection: a cross-sectional study. Andrologia 53(5):e13979
pubmed: 33774838
doi: 10.1111/and.13979
Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ (2000) High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J Biol Chem 275(15):11278–11283
pubmed: 10753938
doi: 10.1074/jbc.275.15.11278
Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC (2000) Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol 73(3):231–236
pubmed: 10841964
doi: 10.1016/S0167-5273(00)00221-7
Rämet ME, Rämet M, Lu Q, Nickerson M, Savolainen MJ, Malzone A et al (2003) High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life. J Am Coll Cardiol 41(12):2288–2297
pubmed: 12821261
doi: 10.1016/S0735-1097(03)00481-9
Lotti F, Rastrelli G, Maseroli E, Cipriani S, Guaraldi F, Krausz C et al (2019) Impact of metabolically healthy obesity in patients with andrological problems. J Sex Med 16(6):821–832
pubmed: 30962157
doi: 10.1016/j.jsxm.2019.03.006
Rastrelli G, Lotti F, Reisman Y, Sforza A, Maggi M, Corona G (2019) Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility. Expert Rev Endocrinol Metab 14(5):321–334
pubmed: 31464531
doi: 10.1080/17446651.2019.1657827
Molloy GJ, Stamatakis E, Randall G, Hamer M (2009) Marital status, gender and cardiovascular mortality: behavioural, psychological distress and metabolic explanations. Soc Sci Med 69(2):223–228
pubmed: 19501442
pmcid: 2852675
doi: 10.1016/j.socscimed.2009.05.010
Corona G, Rastrelli G, Monami M, Maseroli E, Jannini EA, Balercia G et al (2013) Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross-sectional and longitudinal analyses. Andrology 1(6):864–871
pubmed: 24127288
doi: 10.1111/j.2047-2927.2013.00139.x
Maggi M, Corona G (2011) Love protects lover’s life. J Sex Med 8(4):931–935
pubmed: 21457464
doi: 10.1111/j.1743-6109.2011.02230.x
Corona G, Bandini E, Fisher A, Elisa M, Boddi V, Balercia G et al (2010) Psychobiological correlates of women’s sexual interest as perceived by patients with erectile dysfunction. J Sex Med 7(6):2174–2183
pubmed: 20412430
doi: 10.1111/j.1743-6109.2010.01812.x
Waite LJ (1995) Does marriage matter? Demography 32(4):483–507
pubmed: 8925942
doi: 10.2307/2061670
Nizamani S, McFarlane RA, Knight-Agarwal CR, Somerset S (2022) Couples-based behaviour change interventions to reduce metabolic syndrome risk. A systematic review. Diabetes Metab Syndr 16(12):102662
pubmed: 36402071
doi: 10.1016/j.dsx.2022.102662
Corona G, Pizzocaro A, Vena W, Rastrelli G, Semeraro F, Isidori AM et al (2021) Diabetes is most important cause for mortality in COVID-19 hospitalized patients: systematic review and meta-analysis. Rev Endocr Metab Disord 22(2):275–296
pubmed: 33616801
pmcid: 7899074
doi: 10.1007/s11154-021-09630-8
Zhang J, Shi W, Zou M, Zeng Q, Feng Y, Luo Z et al (2023) Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis. J Endocrinol Invest 46(4):795–804. https://doi.org/10.1007/s40618-022-01945-w
doi: 10.1007/s40618-022-01945-w
pubmed: 36307637
Katz J, Yue S, Xue W, Gao H (2022) Increased odds ratio for erectile dysfunction in COVID-19 patients. J Endocrinol Investig 45(4):859–864
doi: 10.1007/s40618-021-01717-y
Pizzol D, Shin JI, Trott M, Ilie PC, Ippoliti S, Carrie AM et al (2022) Social environmental impact of COVID-19 and erectile dysfunction: an explorative review. J Endocrinol Investig 45(3):483–487
doi: 10.1007/s40618-021-01679-1
Paoli D, Pallotti F, Anzuini A, Bianchini S, Caponecchia L, Carraro A et al (2023) Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study. J Endocrinol Investig 46(1):89–101
doi: 10.1007/s40618-022-01887-3
Corona G, Vena W, Pizzocaro A, Pallotti F, Paoli D, Rastrelli G et al (2022) Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. J Endocrinol Invest 45(12):2207–2219. https://doi.org/10.1007/s40618-022-01801-x
doi: 10.1007/s40618-022-01801-x
pubmed: 35527294
pmcid: 9080963
Corona G, Baldi E, Isidori AM, Paoli D, Pallotti F, De Santis L et al (2020) SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità). J Endocrinol Investig 43(8):1153–1157
doi: 10.1007/s40618-020-01290-w
Corona G (2022) Erectile dysfunction and premature ejaculation: a continuum movens supporting couple sexual dysfunction. J Endocrinol Investig 45(11):2029–2041
doi: 10.1007/s40618-022-01793-8
Corona G, Rastrelli G, Bartfai G, Casanueva FF, Giwercman A, Antonio L et al (2021) Self-reported shorter than desired ejaculation latency and related distress-prevalence and clinical correlates: results from the European male ageing study. J Sex Med 18(5):908–919
pubmed: 33820727
doi: 10.1016/j.jsxm.2021.01.187
Brody S, Weiss P (2015) Erectile dysfunction and premature ejaculation: interrelationships and psychosexual factors. J Sex Med 12(2):398–404
pubmed: 25382712
doi: 10.1111/jsm.12738
Li H, Xu W, Wang T, Wang S, Liu J, Jiang H (2022) Effect of weight loss on erectile function in men with overweight or obesity: a meta-analysis of randomised controlled trials. Andrologia 54(1):e14250
pubmed: 34644814
doi: 10.1111/and.14250
Gale EA (2005) The myth of the metabolic syndrome. Diabetologia 48(9):1679–1683
pubmed: 16025251
doi: 10.1007/s00125-005-1873-5
Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9):2289–2304
pubmed: 16123508
doi: 10.2337/diacare.28.9.2289
Reaven GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51(6):931–938
pubmed: 15746300
doi: 10.1373/clinchem.2005.048611
Reaven G (2005) Counterpoint: just being alive is not good enough. Clin Chem 51(8):1354–1357
pubmed: 16040841
doi: 10.1373/clinchem.2005.053587
Grundy SM (2005) Point: the metabolic syndrome still lives. Clin Chem 51(8):1352–1354
pubmed: 16040840
doi: 10.1373/clinchem.2005.050989